DEF: Ascend Wellness Seeks Shareholder Approval for Key Proposals

Ascend Wellness Holdings, Inc. announced its 2026 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and reapproval of its stock incentive plan.

Summary

• Ascend Wellness Holdings, Inc. will hold its annual meeting of stockholders virtually on Wednesday, April 29, 2026, at 11:00 a.m. (Eastern Time).
• Stockholders will vote on the election of six directors to the Board, the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm, and the reapproval of the Company's 2021 Stock Incentive Plan.
• The Company's 2021 Stock Incentive Plan is a 10% rolling plan, requiring reapproval every three years by shareholders to continue granting awards.
• As of March 2, 2026, the Company had 202,200,918 Class A Common Shares and 65,000 Class B Common Shares outstanding, with Class B shares carrying 1,000 votes each.
• The Board unanimously recommends voting FOR all proposals.
• The Company uses a virtual meeting format to facilitate broader stockholder participation and achieve cost savings.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a standard corporate governance update, reflecting routine annual meeting proposals and compensation adjustments, with no immediate significant positive or negative operational news. The executive compensation changes, particularly for Mr. Perullo, suggest past internal restructuring.

Positives

• The Board unanimously recommends voting FOR all proposals, indicating internal alignment.
• The Company's decision to host a virtual annual meeting aims to facilitate broader stockholder participation and achieve cost savings.
• The Audit Committee and Board approved the dismissal of the previous auditor, MGO, with no reported disagreements on accounting principles or practices, financial statement disclosure, or auditing scope or procedure.
• The reapproval of the Stock Incentive Plan is designed to attract and retain key talent by aligning their interests with stockholders through equity-based compensation.

Negatives

• Francis Perullo's compensation significantly decreased from $3,849,530 in 2024 to $1,558,615 in 2025, which included a $2,475,000 termination compensation payment in 2024 under a separation agreement, suggesting prior executive role instability despite his current role as President.
• The change of independent registered public accounting firm from Macias Gini & OConnell LLP (MGO) to WithumSmith+Brown, PC, effective March 19, 2025, while stated as having no disagreements, represents a change in a key oversight function.

Future Outlook

The Company intends to continue providing expanded access, improved communication, and cost savings for stockholders through virtual annual meetings. The reapproval of the 2021 Stock Incentive Plan aims to promote the Company's interests by attracting and retaining key personnel and aligning their incentives with stockholder success. The term of the Executive Chairman's employment agreement has been extended through March 31, 2027.

Management Comments

• "We are excited to continue to provide expanded access, improved communication, and cost savings for our stockholders and the Company." (regarding the virtual meeting format)
• "The Board believes the approval of the proposed Plan Resolution is in the best interest of the Company and unanimously recommends a vote FOR the approval of the proposed Plan Resolution."

Industry Context

StockSavvy.ai notes the company operates in the cannabis industry, which is subject to evolving regulatory landscapes. The appointment of Julie Francis, with her extensive commercial and operations experience from MGP Ingredients, The Schwan's Company, and Constellation Brands, suggests a strategic focus on leveraging consumer packaged goods and beverage expertise, potentially signaling growth or market positioning within the cannabis sector. Samuel Brill's background, including serving on the Investment Committee of NewLake Capital Partners, Inc., a cannabis REIT, highlights the importance of specialized financial and investment expertise within this niche industry.

Management Changes

Corporate Governance

Related Party Transactions

• The Company issued a secured promissory note (Massachusetts Note) to a retail dispensary license holder in Massachusetts, providing up to $4.1 million in funding. The borrower was partially owned by an entity managed, in part, by Abner Kurtin, the Company's Executive Chairman.
• The Massachusetts Note accrued interest at 11.5% (later increased to 12.5%) and was settled in September 2025 as part of the borrower's acquisition by a third-party entity. The total principal and interest outstanding at settlement was approximately $4.8 million.

Stakeholder Impact

• Shareholders: Will vote on key corporate governance matters, including director elections, auditor ratification, and the stock incentive plan. The virtual meeting format aims to improve access and participation.
• Employees, Officers, Consultants, Advisors, and Non-Employee Directors: The reapproval of the Stock Incentive Plan directly impacts their ability to receive equity-based compensation, which is designed to attract, retain, and incentivize them.
• Management: Executive compensation details are provided, including base salaries, bonuses, and equity awards, reflecting the Company's compensation philosophy and recent changes in executive roles and pay structures.

Next Steps

• Stockholders to vote on proposals at the virtual Annual Meeting on April 29, 2026.
• The Compensation and Corporate Governance Committee will finalize annual bonus amounts for fiscal year 2025.
• The Company will continue to operate under the reapproved 2021 Stock Incentive Plan, if approved by stockholders.
• Stockholders may submit proposals for the 2027 annual meeting by November 20, 2026 (Rule 14a-8) or provide advance notice for nominations/business between January 4, 2027, and February 3, 2027 (bylaws).

Key Dates

Recommendation

The filing is a routine proxy statement for an annual meeting, outlining standard corporate governance matters, director elections, auditor ratification, and executive compensation. It does not contain new financial results, strategic shifts, or material operational updates that would warrant a change in investment posture. The reapproval of the stock incentive plan is a standard practice to align management and shareholder interests, and the executive changes, while notable, appear to be part of past restructuring and are now established.

Keywords

Ascend Wellness, AWH, Proxy Statement, Annual Meeting, Corporate Governance, Director Election, Auditor Ratification, Stock Incentive Plan, Executive Compensation, Cannabis Industry